251 related articles for article (PubMed ID: 10214691)
1. Proteases of protozoan parasites.
Rosenthal PJ
Adv Parasitol; 1999; 43():105-59. PubMed ID: 10214691
[TBL] [Abstract][Full Text] [Related]
2. Development of protease inhibitors for protozoan infections.
McKerrow JH; Rosenthal PJ; Swenerton R; Doyle P
Curr Opin Infect Dis; 2008 Dec; 21(6):668-72. PubMed ID: 18978536
[TBL] [Abstract][Full Text] [Related]
3. The proteases and pathogenicity of parasitic protozoa.
McKerrow JH; Sun E; Rosenthal PJ; Bouvier J
Annu Rev Microbiol; 1993; 47():821-53. PubMed ID: 8257117
[TBL] [Abstract][Full Text] [Related]
4. Characterization and role of protozoan parasite proteasomes.
Paugam A; Bulteau AL; Dupouy-Camet J; Creuzet C; Friguet B
Trends Parasitol; 2003 Feb; 19(2):55-9. PubMed ID: 12586468
[TBL] [Abstract][Full Text] [Related]
5. Drugs targeting parasite lysosomes.
Doyle PS; Sajid M; O'Brien T; Dubois K; Engel JC; Mackey ZB; Reed S
Curr Pharm Des; 2008; 14(9):889-900. PubMed ID: 18473838
[TBL] [Abstract][Full Text] [Related]
6. Targeting DHFR in parasitic protozoa.
Anderson AC
Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis of erythrocyte proteins by proteases of malaria parasites.
Rosenthal PJ
Curr Opin Hematol; 2002 Mar; 9(2):140-5. PubMed ID: 11844998
[TBL] [Abstract][Full Text] [Related]
8. Antiparasitic therapy.
Kappagoda S; Singh U; Blackburn BG
Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
[TBL] [Abstract][Full Text] [Related]
9. Biological roles of proteases in parasitic protozoa.
Klemba M; Goldberg DE
Annu Rev Biochem; 2002; 71():275-305. PubMed ID: 12045098
[TBL] [Abstract][Full Text] [Related]
10. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
McKerrow JH
Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
[TBL] [Abstract][Full Text] [Related]
11. New approaches for the identification of drug targets in protozoan parasites.
Müller J; Hemphill A
Int Rev Cell Mol Biol; 2013; 301():359-401. PubMed ID: 23317822
[TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerases as targets for antiprotozoal therapy.
Bakshi RP; Shapiro TA
Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
[TBL] [Abstract][Full Text] [Related]
13. Antiparasitic drugs.
Yoshikawa TT
Am Fam Physician; 1980 Mar; 21(3):132-8. PubMed ID: 7355683
[TBL] [Abstract][Full Text] [Related]
14. [Target points of antiparasitic drugs].
Boczoń K
Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
[No Abstract] [Full Text] [Related]
15. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.
Coombs GH; Goldberg DE; Klemba M; Berry C; Kay J; Mottram JC
Trends Parasitol; 2001 Nov; 17(11):532-7. PubMed ID: 11872398
[TBL] [Abstract][Full Text] [Related]
16. Drugs Against Protozoan Parasites - a Keystone Symposium.
Moreno SN
IDrugs; 2007 Apr; 10(4):240-2. PubMed ID: 17390243
[No Abstract] [Full Text] [Related]
17. Cysteine proteases in protozoan parasites.
Siqueira-Neto JL; Debnath A; McCall LI; Bernatchez JA; Ndao M; Reed SL; Rosenthal PJ
PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006512. PubMed ID: 30138453
[TBL] [Abstract][Full Text] [Related]
18. The potential use of melatonin to treat protozoan parasitic infections: A review.
Daryani A; Montazeri M; Pagheh AS; Sharif M; Sarvi S; Hosseinzadeh A; Reiter RJ; Hadighi R; Joghataei MT; Ghaznavi H; Mehrzadi S
Biomed Pharmacother; 2018 Jan; 97():948-957. PubMed ID: 29136773
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Drug Resistance in Protozoal Diseases.
Capela R; Moreira R; Lopes F
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731801
[TBL] [Abstract][Full Text] [Related]
20. [Physiopathology of protozoan infections].
Hommel M
C R Seances Soc Biol Fil; 1996; 190(4):341-55. PubMed ID: 8952886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
